Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 15, 2023
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
Fri, May 12, 2023
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
Terence Flynn Maintained (CCCC) at Sell with Decreased Target to $3 on, May 12th, 2023
Terence Flynn of Morgan Stanley, Maintained "C4 Therapeutics, Inc." (CCCC) at Sell with Decreased Target from $5 to $3 on, May 12th, 2023.
Terence has made no other calls on CCCC in the last 4 months.
There are 3 other peers that have a rating on CCCC. Out of the 3 peers that are also analyzing CCCC, 1 agrees with Terence's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Chi Fong of "B of A Securities" Maintained at Hold with Decreased Target to $5 on, Tuesday, March 28th, 2023
These are the ratings of the 2 analyists that currently disagree with Terence
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $25 on, Monday, May 8th, 2023
- Eric Joseph of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $5 on, Friday, February 24th, 2023
